retatrutide side effects clinical trials 2025 Retatrutide—A Game Changer in Obesity Pharmacotherapy Lilly's retatrutide shows 28% weight

The medication works by activating GLP-1 receptors throughout the digestive tract, which alters gut motility and slows gastric emptying

Parallel efforts are exploring new indications, including neurodegenerative and substance use disorders, metabolic liver disease, arthritis, type 1 diabetes and inflammatory bowel disease

In this BONUS episode, Associate Editor and Clinical Pharmacist Vickie Danaher breaks down the new Medicare GLP-1 Bridge programwhat it is, how it works, and what pharmacy teams need to know right now

These combined mechanisms can improve fat metabolism, reduce inflammation, and preserve lean muscle during fat loss

These foods also stabilize energy levels, which reduces cravings and supports the medication's weight loss benefits throughout the week

Prescription Rules and Access All GLP-1 drugs are prescription-only treatments